- Page 1 and 2: Training Supplement Winter 10 Journ
- Page 3 and 4: U.S. SPECIAL OPERATIONS COMMAND TAC
- Page 5 and 6: HIV Post Exposure Prophylaxis 45 Hy
- Page 7 and 8: Changes for 2009: A. Crush Protocol
- Page 9 and 10: ABDOMINAL PAIN SPECIAL CONSIDERATIO
- Page 11 and 12: ALTITUDE ILLNESS SPECIAL CONSIDERAT
- Page 13 and 14: ANAPHYLACTIC REACTION SPECIAL CONSI
- Page 15 and 16: BACK PAIN SPECIAL CONSIDERATIONS: M
- Page 17 and 18: BEHAVIORAL CHANGES (INCLUDES PSYCHO
- Page 19 and 20: Winter 2010 Training Supplement TME
- Page 21 and 22: Winter 2010 Training Supplement TME
- Page 23 and 24: Winter 2010 Training Supplement TME
- Page 25 and 26: BRONCHITIS/ PNEUMONIA SPECIAL CONSI
- Page 27: CHEST PAIN SPECIAL CONSIDERATIONS:
- Page 31 and 32: CORNEAL ABRASIONS/ CORNEAL ULCERS/
- Page 33 and 34: CRUSH SYNDROME PROTOCOL SPECIAL CON
- Page 35 and 36: DEEP VENOUS THROMBOSIS (DVT) SPECIA
- Page 37 and 38: DENTAL PAIN SPECIAL CONSIDERATIONS:
- Page 39 and 40: EAR INFECTION (INCLUDES OTITIS MEDI
- Page 41 and 42: EPISTAXIS SPECIAL CONSIDERATIONS: 1
- Page 43 and 44: FUNGAL SKIN INFECTION SPECIAL CONSI
- Page 45 and 46: HEADACHE SPECIAL CONSIDERATIONS: 1.
- Page 47 and 48: HIV POST EXPOSURE PROPHYLAXIS SPECI
- Page 49 and 50: HYPERTHERMIA SPECIAL CONSIDERATIONS
- Page 51 and 52: INGROWN TOENAIL SPECIAL CONSIDERATI
- Page 53 and 54: K-9 EVALUATION AND TREATMENT VITAL
- Page 55 and 56: HYDRATION STATUS: 1. Normal Hydrati
- Page 57 and 58: K-9 HIGH ALTITUDE SICKNESS AND PULM
- Page 59 and 60: K-9 TRAUMA MANAGEMENT SPECIAL CONSI
- Page 61 and 62: C. Chest tube and needle thoracente
- Page 63 and 64: MALARIA SPECIAL CONSIDERATIONS: 1.
- Page 65 and 66: NAUSEA AND VOMITING SPECIAL CONSIDE
- Page 67 and 68: SEIZURE SPECIAL CONSIDERATIONS: 1.
- Page 69 and 70: SMOKE INHALATION SPECIAL CONSIDERAT
- Page 71 and 72: SPECIAL CONSIDERATIONS: None SUBUNG
- Page 73 and 74: MILD TRAUMATIC BRAIN INJURY (MTBI)
- Page 75 and 76: URINARY TRACT INFECTION SPECIAL CON
- Page 77 and 78: Additional Contributors to Earlier
- Page 79 and 80:
Joint Special Operations Tactical M
- Page 81 and 82:
Pregnancy Category X Studies in ani
- Page 83 and 84:
o Increased fluid intake is require
- Page 85 and 86:
Pregnancy Category B Side-effects:
- Page 87 and 88:
Dosage of atovaquone/proguanil in p
- Page 89 and 90:
o Hepatitis Immune system disorder
- Page 91 and 92:
o o Gastroenteritis Protocol Urinar
- Page 93 and 94:
Benadryl® - See Diphenhydramine HC
- Page 95 and 96:
Pregnancy class: Generally consider
- Page 97 and 98:
2nd generation: Diminished Staph au
- Page 99 and 100:
o o o o o o o o Vomiting Diarrhea
- Page 101 and 102:
Dextrose - See Glutose Diamox® - S
- Page 103 and 104:
o o o Contact Dermatitis Protocol E
- Page 105 and 106:
o Hypersensitivity to other carbape
- Page 107 and 108:
o Days 3 to 7: Instill 1 drop in af
- Page 109 and 110:
o Renal impairment o Not for use in
- Page 111 and 112:
o Heme and lymphatic system Anemia
- Page 113 and 114:
on the label. DO NOT use solutions
- Page 115 and 116:
o Sodium depletion o Transient volu
- Page 117 and 118:
Abdominal pain Fatigue Loss of ap
- Page 119 and 120:
o Sedation in combination with anal
- Page 121 and 122:
o Ileus o Urinary retention TMEP Us
- Page 123 and 124:
o Swelling o Contact dermatitis o I
- Page 125 and 126:
Indications: o HAPE prophylaxis/tre
- Page 127 and 128:
o Ventilatory support o Intravenous
- Page 129 and 130:
Motion sickness: The average adult
- Page 131 and 132:
o GI: Nausea, vomiting, anorexia, d
- Page 133 and 134:
o Dry mouth o Nausea o Vomiting Adv
- Page 135 and 136:
o Respiratory: throat irritation, a
- Page 137 and 138:
Metabolism and nutrition disorders
- Page 139 and 140:
decrease the efficacy of tadalafil
- Page 141 and 142:
Acute renal failure Nephrogenic di
- Page 143 and 144:
Common Name Nomenclature AHFS Categ
- Page 145 and 146:
dextrose tablets 45gm multi-use squ
- Page 147 and 148:
plastic bag 12s (Hespan) 12s ibupro
- Page 149 and 150:
moxifloxacin hydrochloride (Avelox)
- Page 151 and 152:
Primaquine Phosphate tablets USP 15
- Page 153 and 154:
2009 Joint Formulary Authors U.S. S
- Page 155 and 156:
Pediatric Vital Signs Respiratory R
- Page 157 and 158:
systems. Through the medical threat
- Page 159 and 160:
Where do you foresee taking casualt
- Page 161 and 162:
Medics Advanced providers Casualty
- Page 163 and 164:
After Action Review in Training or
- Page 165 and 166:
Access to evacuation routes (foot,
- Page 167 and 168:
Winter 2010 Training SupplementTact
- Page 169 and 170:
Winter 2010 Training SupplementTact
- Page 171 and 172:
- Patient Treatment & Monitoring on
- Page 173 and 174:
• Open HMMWV / GMV • Unit speci
- Page 175 and 176:
REHEARSALS Drive routes to hospital
- Page 177 and 178:
SEVERITY Minor: o partial thickn
- Page 179 and 180:
(Retrieved from http://www.nda.ox.a
- Page 181 and 182:
NOTES: Winter 2010 Training Supplem
- Page 183 and 184:
Winter 2010 Training Supplement 181